CP and metabolic dysfunction-associated steatotic liver disease: It is reported that downregulation of hepatic ceruloplasmin results in the restoration of hepatic copper level, which attenuates liver steatosis by targeting copper-SOC1-AMPK signaling pathway in NAFLD mice model (20).